Precision BioSciences, Inc.
DTIL
$7.01
$0.152.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 10.33% | 213.46% | -32.55% | -171.82% | -339.46% |
| Total Depreciation and Amortization | -9.22% | -10.44% | -33.33% | -49.64% | -50.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 457.30% | -86.75% | 1,093.20% | 214.22% | 124.26% |
| Change in Net Operating Assets | -352.20% | -3,120.31% | -80.96% | 94.11% | 93.63% |
| Cash from Operations | 37.35% | 39.78% | -158.29% | -36.33% | -0.37% |
| Capital Expenditure | 71.88% | 80.41% | 100.00% | 92.86% | 25.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 60.00% | -- | 100.00% | -- | -- |
| Cash from Investing | 63.69% | -235.05% | 126.56% | 57.14% | -1,107.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -93.03% | 1,204.98% | -55.76% | 654.99% | -73.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -93.03% | 1,209.39% | -55.56% | 654.99% | -73.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.27% | 612.76% | -506.06% | -5.55% | -141.16% |